Synbio Tech Inc. (TPEX:1295)
38.20
-2.80 (-6.83%)
Nov 20, 2026, 1:30 PM CST
Synbio Tech Revenue
Synbio Tech had revenue of 233.36M TWD in the quarter ending September 30, 2026, with 10.44% growth. This brings the company's total for the last twelve months to 1.03B, up 2.80% year-over-year. In the year 2025, Synbio Tech had annual revenue of 1.04B with 4.97% growth. That makes Synbio Tech the 31,163rd largest company in the world by revenue and 1,555th in Taiwan.
Revenue (ttm)
1.03B
Revenue Growth
+2.80%
P/S Ratio
1.28
Revenue / Employee
11.18M
Employees
92
Market Cap
1.32B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Synbio Tech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.04B | 49.19M | 4.97% |
| Dec 31, 2024 | 989.48M | 166.18M | 20.18% |
| Dec 31, 2023 | 823.30M | 83.98M | 11.36% |
| Dec 31, 2022 | 739.33M | -116.46M | -13.61% |
| Dec 31, 2021 | 855.79M | 118.34M | 16.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GenMont Biotech Incorporation | 396.64M |
| Abnova (Taiwan) | 337.63M |
| NeoCore Technology | 271.62M |
| G&E Herbal Biotechnology | 170.13M |
| TaiRx | 29.44M |
| Anti-Microbial Savior BioteQ | 1.26M |